Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 18
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    do Prado, Gladys Villas Boas Marchi, Ana Paula Moreno, Luisa Zanolli Rizek, Camila Amigo, Ulisses Moreno, Andrea Micke Rossi, Flavia Guimaraes, Thais Levin, Anna Sara and Costa, Silvia F. 2016. Virulence and resistance pattern of a novel sequence type of linezolid-resistant Enterococcus faecium identified by whole-genome sequencing. Journal of Global Antimicrobial Resistance, Vol. 6, p. 27.


    Klare, Ingo Fleige, Carola Geringer, Uta Thürmer, Alexander Bender, Jennifer Mutters, Nico T. Mischnik, Alexander and Werner, Guido 2015. Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. Journal of Global Antimicrobial Resistance, Vol. 3, Issue. 2, p. 128.


    Qazi, Junaid Casserly, Liam F. O'Connor, Ciara Finnegan, Cathriona Power, Lorraine Dunne, Colum P. and O'Connell, Nuala H. 2015. A case of fatal daptomycin-resistant, vancomycin-resistant enterococcal infective endocarditis in end-stage kidney disease. JMM Case Reports, Vol. 2, Issue. 5,


    Rybak, Jeffrey M. and Roberts, Karrine 2015. Tedizolid Phosphate: a Next-Generation Oxazolidinone. Infectious Diseases and Therapy, Vol. 4, Issue. 1, p. 1.


    Bassetti, M. Baguneid, M. Bouza, E. Dryden, M. Nathwani, D. and Wilcox, M. 2014. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical Microbiology and Infection, Vol. 20, p. 3.


    Chastre, J. Blasi, F. Masterton, R.G. Relio, J. Torres, A. and Welte, T. 2014. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical Microbiology and Infection, Vol. 20, p. 19.


    Liou, Douglas Z. Barmparas, Galinos Ley, Eric J. Salim, Ali Tareen, Aasin Casas, Tamara Lee, Debora and Bukur, Marko 2014. To swab or not to swab? A prospective analysis of 341 SICU VRE screens. Journal of Trauma and Acute Care Surgery, Vol. 76, Issue. 5, p. 1192.


    Nateghian, Alireza Ghasemi Ahari, Seyed Mohammad Lahouti Harahdashti, Arash Navidnia, Masoumeh and Mehrazma, Mitra 2014. Prevalence of Vancomycin-resistant Enterococci Colonization, and Susceptibility to linezolid in Pediatric Intensive Care Units of a Referral Pediatric Center in Tehran, Iran. Archives of Pediatric Infectious Diseases, Vol. 3, Issue. 2,


    Ramaswamy, Divya Pradeep Amodio-Groton, Maria and Scholand, Stephen J 2013. Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: a short case series. BMC Urology, Vol. 13, Issue. 1,


    Tang, Hung-Jen Chen, Chi-Chung Zhang, Chun-Cheng Su, Bo-An Li, Chien-Ming Weng, Tzu-Chieh Chiang, Shyh-Ren Ko, Wen-Chien and Chuang, Yin-Ching 2013. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates. Diagnostic Microbiology and Infectious Disease, Vol. 77, Issue. 3, p. 254.


    Calfee, David P. 2012. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Current Opinion in Infectious Diseases, Vol. 25, Issue. 4, p. 385.


    Flamm, Robert K Farrell, David J Mendes, Rodrigo E Ross, James E Sader, Helio S and Jones, Ronald N 2012. ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries. Journal of Chemotherapy, Vol. 24, Issue. 6, p. 328.


    Biedenbach, Douglas J. Farrell, David J. Mendes, Rodrigo E. Ross, James E. and Jones, Ronald N. 2010. Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program. Diagnostic Microbiology and Infectious Disease, Vol. 68, Issue. 4, p. 459.


    Canton, R. Ruiz-Garbajosa, P. Chaves, R. L. and Johnson, A. P. 2010. A potential role for daptomycin in enterococcal infections: what is the evidence?. Journal of Antimicrobial Chemotherapy, Vol. 65, Issue. 6, p. 1126.


    Chiappini, Elena Conti, Camilla Galli, Luisa and de Martino, Maurizio 2010. Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review. Clinical Therapeutics, Vol. 32, Issue. 1, p. 66.


    Goldberg, E. Paul, M. Talker, O. Samra, Z. Raskin, M. Hazzan, R. Leibovici, L. and Bishara, J. 2010. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. Journal of Antimicrobial Chemotherapy, Vol. 65, Issue. 8, p. 1779.


    Rossolini, Gian Maria Mantengoli, Elisabetta Montagnani, Francesca and Pollini, Simona 2010. Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Current Opinion in Microbiology, Vol. 13, Issue. 5, p. 582.


    Nguyen, S. Pasquet, A. Legout, L. Beltrand, E. Dubreuil, L. Migaud, H. Yazdanpanah, Y. and Senneville, E. 2009. Efficacy and tolerance of rifampicin–linezolid compared with rifampicin–cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clinical Microbiology and Infection, Vol. 15, Issue. 12, p. 1163.


    ×

Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium

  • B. SCHULTE (a1), A. HEININGER (a2), I. B. AUTENRIETH (a1) and C. WOLZ (a1)
  • DOI: http://dx.doi.org/10.1017/S0950268807009508
  • Published online: 01 September 2007
Abstract
SUMMARY

During 2004 and at the start of 2005 a university hospital in Southwest Germany was affected by an extensive outbreak of vancomycin-resistant Enterococcus faecium (VRE). Although the outbreak was contained, linezolid-resistant enterococci emerged during and after the outbreak as the usage of linezolid became more common. Linezolid resistance was no longer limited to VRE. Nosocomial spread of linezolid-resistant but vancomycin-susceptible E. faecium was detected and these strains also emerged in patients without prior drug exposure. Linezolid should therefore be used with caution and the susceptibility of isolates monitored over time. Isolation precautions and screening of contacts should be considered to avoid spread of resistant isolates.

Copyright
Corresponding author
*Author for correspondence: Dr B. Schulte, Institut für Medizinische Mikrobiologie und Hygiene, Eberhard-Karls-Universität, Elfriede-Aulhorn-Str. 6, D-72076 Tübingen, Germany. (Email: berit.schulte@med.uni-tuebingen.de)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. J Brauers , Surveillance of linezolid resistance in Germany, 2001–2002. Clinical Microbiology and Infection 2005; 11: 3946.

2. VG Meka , HS Gold . Antimicrobial resistance to linezolid. Clinical Infectious Diseases 2004; 39: 10101015.

3. II Raad , Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrobial Agents and Chemotherapy 2004; 48: 35833585.

4. RD Gonzales , Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001; 357: 1179.

5. MP Pai , Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clinical Infectious Diseases 2002; 35: 12691272.

6. S Borgmann , Discrimination between epidemic and non-epidemic glycopeptide-resistant E. faecium in a post-outbreak situation. Journal of Hospital Infection 2007. Published online: 30 July 2007. doi:10.1016/j.jhin.2007.06.002.

8. SH Marshall , Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 2002; 46: 33343336.

9. B Schulte , Linezolid-resistant E. faecium isolated from an open joint fracture: a report of the first isolate from Italy? International Journal of Hygiene and Environmental Health 2005; 208: 477480.

10. RN Jones , Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagnostic Microbiology and Infectious Disease 2002; 42: 137139.

11. S Rahim , Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clinical Infectious Diseases 2003; 36: E146E148.

12. MG Bonora , Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. European Journal of Clinical Microbiology and Infectious Diseases 2006; 25: 197198.

13. IA Herrero , NC Issa , R Patel . Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. New England Journal of Medicine 2002; 346: 867869.

14. TE Dobbs , Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. Journal of Clinical Microbiology 2006; 44: 33683370.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×